Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 22:29:09 GMT 2025
by
admin
on
Mon Mar 31 22:29:09 GMT 2025
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | IGG1|KAPPA |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
WX1WTN0Y15
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
BC-06
Created by
admin on Mon Mar 31 22:29:09 GMT 2025 , Edited by admin on Mon Mar 31 22:29:09 GMT 2025
|
PRIMARY | |||
|
CHEMBL3544922
Created by
admin on Mon Mar 31 22:29:09 GMT 2025 , Edited by admin on Mon Mar 31 22:29:09 GMT 2025
|
PRIMARY | |||
|
DB14959
Created by
admin on Mon Mar 31 22:29:09 GMT 2025 , Edited by admin on Mon Mar 31 22:29:09 GMT 2025
|
PRIMARY | |||
|
WX1WTN0Y15
Created by
admin on Mon Mar 31 22:29:09 GMT 2025 , Edited by admin on Mon Mar 31 22:29:09 GMT 2025
|
PRIMARY | |||
|
C170259
Created by
admin on Mon Mar 31 22:29:09 GMT 2025 , Edited by admin on Mon Mar 31 22:29:09 GMT 2025
|
PRIMARY | |||
|
1422268-07-2
Created by
admin on Mon Mar 31 22:29:09 GMT 2025 , Edited by admin on Mon Mar 31 22:29:09 GMT 2025
|
PRIMARY | |||
|
100000180096
Created by
admin on Mon Mar 31 22:29:09 GMT 2025 , Edited by admin on Mon Mar 31 22:29:09 GMT 2025
|
PRIMARY | |||
|
Opicinumab
Created by
admin on Mon Mar 31 22:29:09 GMT 2025 , Edited by admin on Mon Mar 31 22:29:09 GMT 2025
|
PRIMARY | |||
|
10090
Created by
admin on Mon Mar 31 22:29:09 GMT 2025 , Edited by admin on Mon Mar 31 22:29:09 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 1_145 | 1_201 |
| 1_262 | 1_322 |
| 1_368 | 1_426 |
| 2_22 | 2_96 |
| 2_145 | 2_201 |
| 2_262 | 2_322 |
| 2_368 | 2_426 |
| 3_23 | 3_88 |
| 3_135 | 3_195 |
| 4_23 | 4_88 |
| 4_135 | 4_195 |
| 1_221 | 3_215 |
| 2_221 | 4_215 |
| 1_227 | 2_227 |
| 1_230 | 2_230 |
| Glycosylation Type | MAMMALIAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_298 |
| N | 2_298 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Experimental drug investigated as a treatment to promote myelin repair in multiple sclerosis.
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|